← Back to Clinical Trials
Recruiting NCT05991739

NCT05991739 Pilot Testing of a Structural Racism Intervention for Immigrant Latinx Families

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05991739
Status Recruiting
Phase
Sponsor University of Illinois at Chicago
Condition Stress, Psychological
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2023-11-02
Primary Completion 2024-08

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Familias Inmigrantes Empoderándose contra eStrés Tomando Acción (FIESTA)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2023-11-02 with a primary completion date of 2024-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to evaluate a new, community-based, group intervention called FIESTA (Familias Inmigrantes Empoderándose contra eStrés Tomando Acción) to understand how well it helps Latinx immigrant families deal with the impact of stress due to structural racism. Structural racism is defined as the policies, practices, and norms that work together to limit equal opportunities for minority communities. For Latinx immigrant families, this can include fears of deportation, lack of bilingual providers, and discrimination. These experiences of structural racism can turn into stress, which impacts well-being and mental health. Researchers will investigate if: 1) FIESTA lowers stress and mental health symptoms (anxiety/depression) and increases feelings of empowerment, improved knowledge of resources, better parent-youth relationship quality, and higher use of healthy coping skills; and 2) FIESTA is feasible (easy to carry out), acceptable (agreeable or satisfactory), and appropriate (relevant to the needs of Latinx families). FIESTA is ten-sessions and will be led by two community health workers. Researchers will enroll 35 parent-adolescent dyads (35 study-eligible parents and 35 study-eligible youth) in the initial study. This study will randomize parent-youth dyads to the treatment arm or waitlist-control arm using block randomization. In other words, participants will be randomly assigned to one of two groups, the First Group, or the Second Group. The First Group will begin immediately, and the Second Group will begin after three months. Data will be collected at baseline and three- and six-month post-baseline.

Eligibility Criteria

Inclusion Criteria: Caregiver/Parent * Identification as a Latina immigrant woman over the age of 18 years old * Parent or primary caregiver of a youth between the ages of 14-17 Youth * Identification as a Latinx adolescent between the ages of 14-17 * Child of a primary caregiver (mother) who identifies as a Latina immigrant Exclusion Criteria: * Adults and youth unable to cognitively participate in the group or adults who are unable to consent

Contact & Investigator

Central Contact

Stephanie A Torres, PhD

✉ satorres@uic.edu

📞 312-996-7327

Principal Investigator

Stephanie A Torres, PhD

PRINCIPAL INVESTIGATOR

University of Illinois at Chicago

Frequently Asked Questions

Who can join the NCT05991739 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 17 Years, studying Stress, Psychological. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05991739 currently recruiting?

Yes, NCT05991739 is actively recruiting participants. Contact the research team at satorres@uic.edu for enrollment information.

Where is the NCT05991739 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT05991739 clinical trial?

NCT05991739 is sponsored by University of Illinois at Chicago. The principal investigator is Stephanie A Torres, PhD at University of Illinois at Chicago. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology